
Keywords: LIP; labile iron pool; FAC; Ferric Ammonium Citrate; DCF-DA; dichlorofluorescein-diacetate; PI; propidium iodide; IO; iron-overloaded; MFPs; mammary fat pads; IP; intraperitoneal injection; CA-AM; calcein acetoxymethyl ester; FACS; Fluorescence Activated